logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
T

Therapeutic Advances in Hematology

IF3.1
Papers558
Citations1333
Journal Papers 554
Publication Date
delete
Low dose chidamide promotes inhibitory Fcγ receptorIIb expression on monocytes in ITP: A translational study of human ITP samples and ITP murine models
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-10-01
delete0
PREAI
deleteHongyu Zhao; Wenjing Liu; Haoyi Wang; Daqi Li; Chen Su; Meili Sun; Xinguang Liu; Lu Sun; Juan Wang; Xiaodong Qiu; Guihuan Li; Meijuan Xue; Guohai Su; Ming Hou; Yu Hou
deleteShare
deleteSave
Precision medicine in acute lymphoblastic leukemia: A narrative review of current strategies and future directions
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-10-01
delete0
PREAI
deleteSondus Jawad; Maria Benkhadra; Giuseppe Saglio; Rola Ghasoub; Mohamed A. Yassin
deleteShare
deleteSave
Targeted therapies in immune thrombocytopenia: Current landscape and future directions
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-10-01
delete0
PREAI
deleteTomás José González-López
deleteShare
deleteSave
Real-world effectiveness of pegcetacoplan in individuals with paroxysmal nocturnal haemoglobinuria and suboptimal response to C5 inhibitors
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-10-01
delete0
PREAI
deleteŁukasz Szukalski; Jaroslav Čermák; Lenka Mastíková; Ana Boban; Sławomir Jurek; Patrycja Mensah-Glanowska; Anna Szmigielska-Kapłon; Justyna Kozińska; Karla Rener; Paweł Bernatowicz; Elżbieta Kalicińska; Delia Soare; Andrzej Balcerzak; Horia Bumbea; Marek Hus; Jerzy Windyga; Marta Sobas; Jarosław Czyż
deleteShare
deleteSave
Perioperative discovery of KLKB1 c.451dupT mutation causing prekallikrein deficiency in a Saudi child: A case report of safe surgery despite isolated severe aPTT prolongation
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-28
delete0
PREAI
deleteFaisal A. Alghamdi; Khalid Alahmadi; Asim Alamri; Amr Elyas; Mohamed Elsaid
deleteShare
deleteSave
Paroxysmal nocturnal hemoglobinuria perspective: Lactate Dehydrogenase (LDH) as a surrogate endpoint
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-26
delete0
PREAI
deleteMorag Griffin; Christopher J. Patriquin; Jun-Ho Jang
deleteShare
deleteSave
Molecular overlap between primary immune thrombocytopenia and inherited platelet disorders: A pediatric case report with a novel heterozygous ITGB3 variant identified by next-generation sequencing
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-19
delete0
PREAI
deleteFélix David Duarte Rodríguez; Óscar Eduardo González Figueredo; Alejandra Calderón Gasca
deleteShare
deleteSave
Impact of luspatercept in beta-thalassemia major with alloimmunization: A case report
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-18
delete0
PREAI
deleteFariha Fairouz; Supat Chamnanchanunt; Vipa Thanachartwet; Varunee Desakorn; Suthat Fucharoen
deleteShare
deleteSave
Efficacy and safety of different TPO-RAs combined with cyclosporine in the treatment of NSAA
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-15
delete0
PREAI
deleteTing Wang; Boyi Wang; Donglan Liu; Nianbin Li; Shuai Gao; Huaquan Wang; Lijuan Li; Limin Xing; Hong Liu; Guojin Wang; Yuhong Wu; Wen Qu; Jia Song; Jing Guan; Zonghong Shao; Rong Fu
deleteShare
deleteSave
Efficacy and safety of daratumumab-based quadruplet therapy vs non-daratumumab-based triplet therapy in newly diagnosed multiple myeloma patients: A GRADE assessed systematic review and meta-analysis of randomized controlled trials
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-11
delete0
PREAI
deleteMuhammad Osama; Muhammad Haris Khan; Ammara Tahir; Amna Hussain; Ahmad Iftikhar; Aizaz Ali; Safeena Khan; Malak Bilal Hassan; Intikhab Alam; Zeeshan Khan; Abdullah Afridi; Mohammad Ebad Ur Rehman; Amna Gul; Pawan Kumar Thada
deleteShare
deleteSave
Fulminant extramedullary relapse of multiple myeloma with rare cardiac, vascular, and multivisceral involvement: A case report
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-08
delete0
PREAI
deleteYuhui Wei; Xuejiao Yang; Yulan Zheng; Dongdong Zhang
deleteShare
deleteSave
Prognostic value of early lymphocyte dynamics during blinatumomab therapy in relapsed or refractory B-cell precursor acute lymphoblastic leukemia: A real-world retrospective study
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-07
delete0
PREAI
deleteSeonghan Lee; Daehun Kwag; Gi June Min; Sung-Soo Park; Silvia Park; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Hee-Je Kim; Chang-Ki Min; Seok-Goo Cho; Jae-Ho Yoon
deleteShare
deleteSave
Corticosteroids plus statins in patients with primary immune thrombocytopenia and hyperlipidemia: A multicenter retrospective cohort study
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-07
delete0
PREAI
deleteXiran Hou; Yajing Zhao; Jian Chen; Lin Sun; Qiaofeng Dong; Changyong Yuan; Jian Lv; Shuang Liu; Na Gao; Ming Hou; Jun Peng; Zhenyu Yan; Xinguang Liu
deleteShare
deleteSave
A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-04
delete0
PREAI
deleteBing Han; Hui Liu; Guangsheng He; Jinsong Jia; Mei Hong; Jianyu Weng; Shunqing Wang; Fengkui Zhang; Ting Niu; Tianjun Ma; Jinghan Xu; Rong Fu
deleteShare
deleteSave
From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-03
delete0
PREAI
deleteGuluzar Gulnur Itez; Asuman Sunguroğlu
deleteShare
deleteSave
Quality improvement project - Implementation of subcutaneous immunoglobulin in patients with haematological disorders and secondary immunodeficiency
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-02
delete0
PREAI
deleteAmira Chaudry; Rebecca Culpin; Shereen Elshazly
deleteShare
deleteSave
Comparative efficacy and safety of JAK inhibitor-based strategies in JAK inhibitor-naïve myelofibrosis: A systematic review and network meta-analysis
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-02
delete0
PREAI
deleteZhongwang Wang; Linfeng Li; Ting Niu; He Li
deleteShare
deleteSave
More precise risk stratification for de novo acute myeloid leukemia with double-mutation CEBPA
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-09-01
delete0
PREAI
deleteJing jing Liu; Hai ping Yang; Meng Hu
deleteShare
deleteSave
Prognostic value of patient-reported outcome thresholds on survival and adverse events in CLL/SLL: A pooled analysis of ibrutinib trials
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-08-28
delete0
PREAI
deleteAhmad Y. Abuhelwa; Sara A. Almansour; Humaid O. Al-Shamsi; Ziad Abuhelwa; Mohamad A. Ziade; Yasser Bustanji; Mohammad H. Semreen; Mohammad A. Y. Alqudah; Ross A. McKinnon; Karem H. Alzoubi; Michael J. Sorich; Ashley M. Hopkins
deleteShare
deleteSave
Treatment strategies for relapsed/refractory hemophagocytic lymphohistiocytosis in pediatric patients
deleteTherapeutic Advances in Hematology
IF3.1
delete2026-08-27
delete0
PREAI
deleteMan Wang; Lihui Wang; Cuiping Zhu; Zongxuan Huang; YanLing Tao
deleteShare
deleteSave